Eastwood Bio-Medical Canada Inc. (TSXV:EBM)

Market Cap	128.82M +329.9%
Revenue (ttm)	787.78K +19.8%
Net Income	-221.79K
EPS	-0.00
Shares Out	68.89M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,050
Open	1.850
Previous Close	1.870
Day's Range	1.850 - 1.860
52-Week Range	0.345 - 1.970
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 25, 2026

About TSXV:EBM

Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. It also offers Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for bones, teeth, and health; Eleotin G2000 for c...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2010
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: EBM

Financial Performance

In fiscal year 2025, TSXV:EBM's revenue was 782,080, an increase of 11.40% compared to the previous year's 702,076. Losses were -332,767, -27.00% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 10, 2026

Data Sources Report a data error